Who distributes semaglutide in the UK — and why it matters more than you think

The misconception: that 'distributors' sell direct to the public

The most common misunderstanding behind this search is the idea that semaglutide has distributors in the same way that consumer goods do, wholesalers you can approach, bulk suppliers with a trade price, or overseas importers offering a shortcut around UK pharmacy prices. That model does not apply to prescription medicines.

In the UK, Wegovy is manufactured by Novo Nordisk and moves through a tightly regulated chain: manufacturer to licensed wholesaler to GPhC-registered pharmacy. At every step, Medicines and Healthcare products Regulatory Agency (MHRA) rules govern who can hold, handle and supply the product. The pharmacy is the last link, and it can only dispense against a prescription issued by a qualified prescriber after a clinical assessment. There is no legitimate distributor selling semaglutide direct to members of the public, and no legal grey area that permits it.

This is not bureaucratic pedantry. Wegovy is a potent GLP-1 receptor agonist that requires individual clinical assessment precisely because contraindications, drug interactions and dosing decisions are not one-size-fits-all. The regulatory structure around distribution exists to keep patients safe, not to protect market share.

What 'semaglutide distributors' are actually being advertised online

Search results for terms like this surface three main categories of result. First, B2B pharmaceutical logistics companies, these are real wholesalers licensed under the Human Medicines Regulations 2012, but they supply pharmacies and healthcare organisations, not individuals. Second, academic or clinical suppliers of research-grade peptides, these are not the licensed medicine; research peptides are not approved for human use as a weight-loss treatment and are not quality-verified by the MHRA. Third, and most concerning, sellers presenting themselves as overseas or grey-market suppliers.

The MHRA has made its position on this last category clear in successive public warnings. Large seizures of counterfeit and illegally traded weight-loss medicines have been made across the UK, including a 2025 raid on an illicit manufacturing site producing fake tirzepatide pens. Fake pens sold as semaglutide products have been found to contain insulin, a medication that, given in the wrong dose to someone without diabetes, can cause life-threatening hypoglycaemia. If a supplier is not a GPhC-registered UK pharmacy requiring a valid prescription, it sits outside the licensed supply chain. Reporting suspect sellers to the MHRA via the Yellow Card scheme is open to anyone.

Red flags are consistent: offers to supply without clinical assessment, prices far below the market range, payment via unusual methods, and no verifiable UK registration. The absence of a GPhC number you can check is itself the answer.

The legitimate route: GPhC-registered pharmacies and clinical prescribing

For people who want semaglutide for weight management, the only legal and safe route in the UK runs through a prescriber and a registered pharmacy. That applies whether the prescription comes from an NHS specialist service or a regulated private provider.

On the NHS, semaglutide (Wegovy) is available through specialist weight management services under NICE guidance TA875, which sets specific eligibility thresholds and requires multidisciplinary support. Waiting times in many areas are lengthy. Privately, a GPhC-registered online pharmacy can dispense Wegovy once a prescriber has reviewed the consultation and issued a prescription, the same regulatory standard applies either way.

You can verify any UK online pharmacy at the GPhC's public register. It takes about thirty seconds. If a pharmacy cannot be found there, do not order from it. That check is more useful than any review, badge or assurance the site itself provides.

For context on what private treatment typically costs, our weight-loss treatment overview sets out what a transparent all-inclusive price should cover (consultation, clinical review, prescription, and delivery) so you can compare like with like rather than comparing a headline figure against a full-service price.

The NHS medicines page for semaglutide gives a clear summary of how the medicine works, its side-effect profile, and what to discuss with a prescriber. Worth reading before a consultation.

What legitimate clinical oversight actually looks like

One thing patients tell us they wish they had checked earlier: whether their prescriber reviewed their answers personally, or whether the process was automated. At nume, every consultation is read by a GPhC-registered Independent Prescriber, a clinician who can be named and held accountable, not software running eligibility rules.

A real clinical review considers BMI, relevant medical history, current medications, contraindications and goals. For semaglutide specifically, that conversation matters: the dosing schedule starts at 0.25mg and is titrated up from the first dose, moving through the 0.5mg stage and later to the 1mg maintenance dose before some patients progress to the higher 2.4mg level; GI side effects are common early on and worth anticipating; the interaction picture with certain oral medicines, including the contraceptive pill, deserves specific discussion. Our clinical team can work through those questions properly.

Once approved and dispatched by 12pm on a weekday, orders arrive the next working day via tracked DPD, the kind of timeline that fits around a normal schedule rather than requiring a trip to a clinic. The pen goes in the fridge when it arrives; your prescriber's aftercare contact is available if something feels off in the first week.

If you are ready to start that process, begin your free consultation here, there is no obligation before a prescriber has reviewed your information and you have decided to go ahead.